An evolutionary explanation for the presence of cancer nonstem cells in neoplasms

Evolutionary Applications

Volumn 6, Issue 1, 2013, Pages 92-101

  Sprouffske, Kathleen ^a,g   Athena Aktipis, C ^b,c,d   Radich, Jerald P ^e   Carroll, Martin ^a   Nedelcu, Aurora M ^f   Maley, Carlo C ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c University of Arizona   (United States)

^d ARIZONA STATE UNIVERSITY   (United States)

^e Fred Hutchinson Cancer Research Center   (United States)

^f UNIVERSITY OF NEW BRUNSWICK   (Canada)

^g UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84872816286     PISSN: 17524563     EISSN: 17524571     Source Type: Journal    
DOI: 10.1111/eva.12030     Document Type: Article

References (48)

1. Beerenwinkel, N., T. Antal, D. Dingli, A. Traulsen, K. W. Kinzler, V. E. Velculescu, B. Vogelstein et al. 2007. Genetic progression and the waiting time to cancer. PLoS Computational Biology 3:e225.
2. Bissell, M. J., and D. Radisky 2001. Putting tumours in context. Nature Reviews Cancer 1:46-54.
3. Boiko, A. D., O. V. Razorenova, M. van de Rijn, S. M. Swetter, D. L. Johnson, D. P. Ly, P. D. Butler et al. 2010. Human melanoma-initiating cells express neural crest nerve growth factor receptor CD271. Nature 466 13:3-7.
4. Bonnet, D., and J. E. Dick 1997. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nature Medicine 3:730-737.
5. Buss, L. W. 1987. The Evolution of Individuality: Princeton University Press, Princeton, NJ.
6. Cairns, J. 1975. Mutation selection and the natural history of cancer. Nature 255:197-200.
7. Caswell, H. 2001. Matrix population models, 2nd edn. Sinauer Associates, Sunderland, MA.
8. Caussinus, E., and C. Gonzalez 2005. Induction of tumor growth by altered stem-cell asymmetric division in Drosophila melanogaster. Nature Genetics 37:1125-1129.
9. Chao, D. L., J. T. Eck, D. E. Brash, C. C. Maley, and E. G. Luebeck 2008. Preneoplastic lesion growth driven by the death of adjacent normal stem cells. Proceedings of the National Academy of Sciences of the United States of America 105:15034-15039.
10. Chen, J., Y. Li, T.-S. Yu, R. M. McKay, D. K. Burns, S. G. Kernie, and L. F. Parada 2012. A restricted cell population propagates glioblastoma growth after chemotherapy. Nature 488:522-526.
11. Cicalese, A., G. Bonizzi, C. E. Pasi, M. Faretta, S. Ronzoni, B. Giulini, C. Brisken et al. 2009. The tumor suppressor p53 regulates polarity of self-renewing divisions in mammary stem cells. Cell 138:1083-1095.
12. Dingli, D., A. Traulsen, and F. Michor 2007a. (A)symmetric stem cell replication and cancer. PLoS Computational Biology 3:e53.
13. Dingli, D., A. Traulsen, and J. M. Pacheco 2007b. Compartmental architecture and dynamics of hematopoiesis. PLoS ONE 2:e345.
14. Dingli, D., A. Traulsen, and J. M. Pacheco 2007c. Stochastic dynamics of hematopoietic tumor stem cells. Cell Cycle 6:461-466.
15. Driessens, G., B. Beck, A. Caauwe, B. D. Simons, and C. Blanpain 2012. Defining the mode of tumour growth by clonal analysis. Nature 488:527-530.
16. Durrett, R., and D. Schmidt 2008. Waiting for two mutations: with applications to regulatory sequence evolution and the limits of Darwinian evolution. Genetics 180:1501-1509.
17. Ewens, W. J., and G. R. Grant 2005. Statistical methods in bioinformatics: An introduction, 2nd ed: Springer, New York, NY.
18. Greaves, M., and C. C. Maley 2012. Clonal evolution in cancer. Nature 481:306-313.
19. Grimm, V., U. Berger, F. Bastiansen, S. Eliassen, V. Ginot, J. Giske, J. Goss-Custard et al. 2006. A standard protocol for describing individual-based and agent-based models. Ecological Modelling 198:115-126.
20. Gupta, P. B., C. L. Chaffer, and R. A. Weinberg 2009. Cancer stem cells: mirage or reality? Nature Medicine 15:1010-1012.
21. Hanahan, D., and R. A. Weinberg 2000. The hallmarks of cancer. Cell 100:57-70.
22. Hanahan, D., and R. A. Weinberg 2011. Hallmarks of cancer: the next generation. Cell 144:646-674.
23. Kelly, P. N., A. Dakic, J. M. Adams, S. L. Nutt, and A. Strasser 2007. Tumor growth need not be driven by rare cancer stem cells. Science 317:337.
24. Komarova, N. L. 2005. Cancer, aging and the optimal tissue design. Seminars in Cancer Biology 15:494-505.
25. Lapidot, T., C. Sirard, J. Vormoor, B. Murdoch, T. Hoang, J. Caceres-Cortes, M. Minden et al. 1994. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature 367:645-648.
26. Lathia, J. D., M. Hitomi, J. Gallagher, S. P. Gadani, J. Adkins, A. Vasanji, L. Liu et al. 2011. Distribution of CD133 reveals glioma stem cells self-renew through symmetric and asymmetric cell divisions. Cell Death Disease 2:e200.
27. Lefkovitch, L. 1965. The study of population growth in organisms grouped by stages. Biometrics, 21:1-18.
28. Maenhaut, C., J. E. Dumont, P. P. Roger, and W. C. G. van Staveren 2010. Cancer stem cells: a reality, a myth, a fuzzy concept or a misnomer? An analysis. Carcinogenesis 31:149-158.
29. Maynard Smith, J., and E. Szathmáry 1997. The Major Transitions in Evolution. Oxford University Press, USA.
30. McDonald, S. A. C., S. L. Preston, L. C. Greaves, S. J. Leedham, M. A. Lovell, J. A. Z. Jankowski, D. M. Turnbull et al. 2006. Clonal expansion in the human gut: mitochondrial DNA mutations show us the way. Cell Cycle 5:808-811.
31. Merlo, L., J. Pepper, B. Reid, and C. Maley 2006. Cancer as an evolutionary and ecological process. Nature Reviews Cancer 6:924-935.
32. Nowak, M. A., F. Michor, and Y. Iwasa 2003. The linear process of somatic evolution. Proceedings of the National Academy of Sciences of the United States of America 100:14966-14969.
33. Nowell, P. 1976. The clonal evolution of tumor cell populations. Science 194:23-28.
34. O'Brien, C., A. Pollett, S. Gallinger, and J. Dick. 2007. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 445:106-110.
35. Park, S. Y., M. Gönen, H. J. Kim, F. Michor, and K. Polyak 2010. Cellular and genetic diversity in the progression of in situ human breast carcinomas to an invasive phenotype. Journal of Clinical Investment 120:636-644.
36. Pepper, J., K. Sprouffske, and C. Maley 2007. Animal cell differentiation patterns suppress somatic evolution. PLoS Computational Biology 3:e250.
37. Pine, S. R., B. M. Ryan, L. Varticovski, A. I. Robles, and C. C. Harris 2010. Microenvironmental modulation of asymmetric cell division in human lung cancer cells. Proceedings of the National Academy of Sciences of the United States of America 107:2195-2200.
38. Quintana, E., M. Shackleton, M. S. Sabel, D. R. Fullen, T. M. Johnson, and S. J. Morrison 2008. Efficient tumour formation by single human melanoma cells. Nature 456:593-598.
39. Roesch, A., M. Fukunaga-Kalabis, E. C. Schmidt, S. E. Zabierowski, P. A. Brafford, A. Vultur, D. Basu et al. 2010. A temporarily distinct subpopulation of slow-cycling melanoma cells is required for continuous tumor growth. Cell 141:583-594.
40. Rosen, J. M., and C. T. Jordan 2009. The increasing complexity of the cancer stem cell paradigm. Science 324:1670-1673.
41. Royer, C., and X. Lu 2011. Epithelial cell polarity: a major gatekeeper against cancer? Cell Death and Differentiation 18:1470-1477.
42. Sarry, J.-E., K. Murphy, R. Perry, P. V. Sanchez, A. Secreto, C. Keefer, C. R. Swider et al. 2011. Human acute myelogenous leukemia stem cells are rare and heterogeneous when assayed in NOD/SCID/IL2Rγc-deficient mice. Journal of Clinical Investment 121:384-395.
43. Schepers, A. G., H. J. Snippert, D. E. Stange, M. van den Born, J. H. van Es, M. van de Wetering, and H. Clevers 2012. Lineage tracing reveals Lgr5 + stem cell activity in mouse intestinal adenomas. Science 337:730-735.
44. Shipitsin, M., L. L. Campbell, P. Argani, S. Weremowicz, N. Bloushtain-Qimron, J. Yao, T. Nikolskaya et al. 2007. Molecular definition of breast tumor heterogeneity. Cancer Cell 11:259-273.
45. Sottoriva, A., P. M. A. Sloot, J. P. Medema, and L. Vermeulen 2010.Exploring cancer stem cell niche directed tumor growth. Cell Cycle 9:1472-1479.
46. Taussig, D. C., F. Miraki-Moud, F. Anjos-Afonso, D. J. Pearce, K. Allen, C. Ridler, D. Lillington et al. 2008. Anti-CD38 antibody-mediated clearance of human repopulating cells masks the heterogeneity of leukemia-initiating cells. Blood 112:568-575.
47. Taussig, D. C., J. Vargaftig, F. Miraki-Moud, E. Griessinger, K. Sharrock, T. Luke, D. Lillington et al. 2010. Leukemia-initiating cells from some acute myeloid leukemia patients with mutated nucleophosmin reside in the CD34(-) fraction. Blood 115:1976-1984.
48. Visvader, J E., and G J. Lindeman 2012. Cancer Stem Cells: Current Status and Evolving Complexities. Cell Stem Cell 10:717-728.